Search

Allogene Therapeutics Inc

Closed

SectorHealthcare

2.09 -0.48

Overview

Share price change

24h

Current

Min

2.06

Max

2.14

Key metrics

By Trading Economics

Income

-3.8M

-43M

EPS

-0.18

Employees

150

EBITDA

-91K

-39M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+328.77% upside

Dividends

By Acuity

Next Earnings

12 Aug 2026

Market Stats

By TradingEconomics

Market Cap

-65M

721M

Previous open

2.57

Previous close

2.09

News Sentiment

By Acuity

26%

74%

81 / 342 Healthcare

Allogene Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

8 Jul 2026, 23:51 UTC

News

Broadcom shares rise in after-market hours as analysts project $172 billion in revenue next year, driven by AI infrastructure spending.

8 Jul 2026, 23:51 UTC

News
Social Media

Costco Wholesale reported net sales of $29.24 billion for June but shares declined in after-hours trading amid mixed investor sentiment and broader market trends.

8 Jul 2026, 23:46 UTC

News
ETF Constituents
Macro News
Correlated Moves

The Financial Select Sector SPDR Fund is higher in after-market trading, supported by strong seasonal patterns and movements in major bank holdings.

8 Jul 2026, 23:41 UTC

News
Social Media
Correlated Moves

Advanced Micro Devices shares are declining in after-hours trading amid negative sentiment in semiconductor stocks, following the announcement of its upcoming earnings report.

8 Jul 2026, 23:41 UTC

Social Media
News

NVIDIA Corp shares declined in after-market trading amid concerns over AI spending and competition. Analysts note cautious investor sentiment contributing to the bearish outlook.

8 Jul 2026, 23:41 UTC

News
Social Media
Correlated Moves

Micron Technology shares traded higher after notable options activity, with $7.2 million in orders for $815 7/17 Puts contributing to a total premium of over $21.5 million.

8 Jul 2026, 23:36 UTC

News

PayPal Holdings Inc. shares fell in after-market trading amid geopolitical tensions and investor risk aversion following President Trump's announcement on the Iran ceasefire.

8 Jul 2026, 23:26 UTC

News

Lam Research Corporation will hold a financial conference call on July 29, 2026, to discuss June quarter results. Shares are higher in after-market trading.

8 Jul 2026, 23:11 UTC

Correlated Moves
Macro News
ETF Constituents
News

The Consumer Discretionary Select Sector SPDR Fund is higher in after-market trading, bolstered by Levi Strauss & Co.'s strong Q2 results and summer performance trends.

8 Jul 2026, 23:06 UTC

News

United Airlines shares traded lower in after-market hours following a judge's ruling to allow a class-action lawsuit over misleading "window seat" charges.

8 Jul 2026, 23:06 UTC

News

Monster Beverage Corp announced a 2-for-1 stock split, effective August 10, 2026. Shares are trading higher in after-market hours following the news.

8 Jul 2026, 23:06 UTC

Correlated Moves
News
Social Media
ETF Constituents

SPDR Dow Jones Industrial Average ETF Trust is lower in after-market hours, reflecting declines in key contributors amid rising inflation concerns from escalating Middle East tensions.

8 Jul 2026, 23:01 UTC

News

Geopolitical tensions following U.S. strikes in Iran have boosted United States Oil Fund LP in after-market trading, reflecting strong upward momentum since Wednesday's close.

8 Jul 2026, 20:13 UTC

ETF Constituents
Correlated Moves
News

The Vanguard Large-Cap ETF is lower in after-hours trading, reflecting broader market declines amid rising crude oil prices and escalating tensions in the Middle East.

8 Jul 2026, 20:07 UTC

News
Correlated Moves

Bitcoin is trading lower amid heightened geopolitical tensions and rising inflation concerns. Earlier in the session, Bitcoin briefly declined significantly before recovering slightly.

8 Jul 2026, 20:07 UTC

News
Correlated Moves

Geopolitical tensions following President Trump's U.S.-Iran ceasefire announcement support a modest rise in CAD/HKD during Wednesday's session. The pair is up since Tuesday's close.

8 Jul 2026, 20:07 UTC

News
Correlated Moves

Bitcoin is trading lower amid heightened geopolitical tensions following President Trump's declaration on Iran. The asset remains under pressure from rising inflation concerns.

8 Jul 2026, 20:06 UTC

Social Media
Macro Event
News

Cisco Systems Inc shares are higher today following the US Wholesale Inventories report, which showed a smaller-than-expected increase for May. Concerns about a price breakdown persist.

8 Jul 2026, 20:04 UTC

News

J B Hunt Transport shares rise as Stephens initiates Overweight rating and TD Cowen raises price target to $265 ahead of earnings report.

8 Jul 2026, 20:04 UTC

Correlated Moves
Social Media
News

Intuit Inc. shares are lower amid an investigation into potential securities fraud by Bleichmar Fonti & Auld LLP related to pricing issues ahead of tax season.

8 Jul 2026, 20:04 UTC

Social Media
News
Correlated Moves

Amazon shares are lower as TD Cowen lowers its price target to $340 ahead of earnings, amid concerns over significant investments and high borrowing.

8 Jul 2026, 20:04 UTC

News
Social Media
Correlated Moves

Alphabet Inc shares are lower despite confirmation of a major presence at the Calgary Stampede, reflecting broader market trends amid global tensions.

8 Jul 2026, 20:04 UTC

News
Correlated Moves

Alphabet Inc shares are lower, affected by declines in the Interactive Media & Services sub-sector and a drop in the S&P 500 Index.

8 Jul 2026, 20:04 UTC

Social Media
News
Correlated Moves

Meta Platforms Inc. shares are lower as France's competition authority mandates renewed negotiations with local media over unpaid publishing fees, amid broader market declines.

8 Jul 2026, 20:04 UTC

Social Media
News
Correlated Moves

Qualcomm Inc is rising amid strong gains in the Semiconductors sector. Social media discussions note key resistance levels around $185.13 and $186.32.

8 Jul 2026, 20:03 UTC

ETF Constituents
News
Correlated Moves

Vanguard Small-Cap ETF is lower as Goldman Sachs warns of waning favorable conditions for small-cap stocks amid rising interest burdens and declining holdings.

8 Jul 2026, 20:03 UTC

Macro News
News
ETF Constituents
Correlated Moves

The Industrial Select Sector SPDR Fund is trading lower as rising oil prices and inflation concerns pressure the sector amid geopolitical tensions.

8 Jul 2026, 20:02 UTC

News

Expedia Group Inc shares declined as geopolitical tensions rose after President Trump's Iran ceasefire remarks, raising concerns about travel demand and costs.

8 Jul 2026, 20:02 UTC

News

NXP Semiconductors NV is trading higher, supported by Cantor Fitzgerald's endorsement and positive outlook for its automotive segment growth through 2027.

8 Jul 2026, 19:57 UTC

Social Media
News

Tesla Inc. shares are lower today amid operational pressures and competitive developments, including scrutiny over Full Self-Driving and new competition in robotics.

Peer Comparison

Price change

Allogene Therapeutics Inc Forecast

Price Target

By TipRanks

328.77% upside

12 Months Forecast

Average 9.09 USD  328.77%

High 14 USD

Low 3.85 USD

Based on 12 Wall Street analysts offering 12 month price targets forAllogene Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

10

Buy

2

Hold

0

Sell

Sentiment

By Acuity

81 / 342 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Allogene Therapeutics Inc

Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell acute lymphoblastic leukemia (ALL). The company also develops cemacabtagene ansegedleucel, an engineered allogeneic CAR T cell product candidate that targets CD19 for the treatment of large B-cell lymphoma; and is in Phase 1b clinical trial for the treatment of chronic lymphocytic leukemia. In addition, it is developing ALLO-715, an allogeneic CAR T cell product candidate that is in a Phase 1 clinical trial for treating R/R multiple myeloma; ALLO-605, an allogeneic CAR T cell product candidate that is in a Phase I clinical trial for the treatment of multiple myeloma; ALLO-647, an anti-CD52 monoclonal antibody; CD70 to treat renal cell cancer; ALLO-316, an allogeneic CAR T cell product candidate that is in Phase 1 clinical trial for the treatment of advanced or metastatic RCC; ALLO-329 for the treatment of certain autoimmune diseases; DLL3 for the treatment of small cell lung cancer and other aggressive neuroendocrine tumors; and Claudin 18.2 for the treatment of gastric and pancreatic cancer. The company has license and collaboration agreements with Pfizer Inc.; Servier; Cellectis S.A.; and Notch Therapeutics Inc. It also has a strategic collaboration agreement with The University of Texas MD Anderson Cancer Center for the preclinical and clinical investigation of allogeneic CAR T cell product candidates; and a strategic partnership with Foresight Diagnostics to develop MRD-based In-Vitro Diagnostic for use in ALPHA3. The company was incorporated in 2017 and is headquartered in South San Francisco, California.
help-icon Live chat